Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Carcinogenesis
|
June 21, 2013
Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations
Nicola Ingram, Emma L Northwood, Sarah L Perry, et al.
International Journal of Cancer
|
October 19, 2023
The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E<sub>2</sub> synthesis and platelet activation in participants of the seAFOod polyp prevention trial
Ge Sun, Harriett Fuller, Hayley Fenton, et al.
BMJ Open
|
March 31, 2022
REducing Colonoscopies in patients without significant bowEl DiseasE: the RECEDE Study - protocol for a prospective diagnostic accuracy study
Christopher Bradley, Siew Wan Hee, Lazaros Andronis, et al.
British Journal of Cancer
|
May 25, 2016
Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme?
Elizabeth Walsh, Colin J Rees, Michael Gill, et al.
The American Journal of Gastroenterology
|
November 3, 2022
Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study
Rebecca J Birch, Nicholas Burr, Venkataraman Subramanian, et al.
Digestion
|
April 28, 2012
Aspirin users attending for NHS bowel cancer screening have less colorectal neoplasia: chemoprevention or false-positive faecal occult blood testing?
Thomas J W Lee, Mark A Hull, Praveen T Rajasekhar, et al.
Cancer Chemotherapy and Pharmacology
|
November 17, 2020
Correction to: Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega‑3 polyunsaturated fatty acid eicosapentaenoic acid
Milene Volpato, Nicola Ingram, Sarah L Perry, et al.
The Journal of Nutrition
|
May 26, 2021
Luminal Bioavailability of Orally Administered ω-3 PUFAs in the Distal Small Intestine, and Associated Changes to the Ileal Microbiome, in Humans with a Temporary Ileostomy
Gael Nana, Suparna Mitra, Henry Watson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
June 1, 2024
APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial
Ge Sun, John R Davies, Tracey Mell, et al.
Cancer Chemotherapy and Pharmacology
|
October 11, 2020
Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid
Milene Volpato, Nicola Ingram, Sarah L Perry, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Carcinogenesis
|
June 21, 2013
Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations
Nicola Ingram, Emma L Northwood, Sarah L Perry, et al.
International Journal of Cancer
|
October 19, 2023
The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E<sub>2</sub> synthesis and platelet activation in participants of the seAFOod polyp prevention trial
Ge Sun, Harriett Fuller, Hayley Fenton, et al.
BMJ Open
|
March 31, 2022
REducing Colonoscopies in patients without significant bowEl DiseasE: the RECEDE Study - protocol for a prospective diagnostic accuracy study
Christopher Bradley, Siew Wan Hee, Lazaros Andronis, et al.
British Journal of Cancer
|
May 25, 2016
Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme?
Elizabeth Walsh, Colin J Rees, Michael Gill, et al.
The American Journal of Gastroenterology
|
November 3, 2022
Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study
Rebecca J Birch, Nicholas Burr, Venkataraman Subramanian, et al.
Digestion
|
April 28, 2012
Aspirin users attending for NHS bowel cancer screening have less colorectal neoplasia: chemoprevention or false-positive faecal occult blood testing?
Thomas J W Lee, Mark A Hull, Praveen T Rajasekhar, et al.
Cancer Chemotherapy and Pharmacology
|
November 17, 2020
Correction to: Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega‑3 polyunsaturated fatty acid eicosapentaenoic acid
Milene Volpato, Nicola Ingram, Sarah L Perry, et al.
The Journal of Nutrition
|
May 26, 2021
Luminal Bioavailability of Orally Administered ω-3 PUFAs in the Distal Small Intestine, and Associated Changes to the Ileal Microbiome, in Humans with a Temporary Ileostomy
Gael Nana, Suparna Mitra, Henry Watson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
June 1, 2024
APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial
Ge Sun, John R Davies, Tracey Mell, et al.
Cancer Chemotherapy and Pharmacology
|
October 11, 2020
Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid
Milene Volpato, Nicola Ingram, Sarah L Perry, et al.
Page
of 9